CDC25C and lung cancer: Through reducing CDC25C and CDC2 protein levels, the heat shock protein 90 (HSP90) inhibitor is implicated in antiproliferative activity and tumor progression in lung cancer cells and thus can be applied for the treatment of lung cancer [46].